Published by Josh White on 28th September 2016
(ShareCast News) - Drug development services and clinical trial management provider Venn Life Sciences announced its unaudited interim results for the six months to 30 June on Wednesday, with revenue of €9.06m, up from €4.25m in the first half of last year.
URL: http://www.digitallook.com/dl/news/story/25014054/...